Skip to main content

Table 2 Logistic regression models: (1) treatment completion; and (2) return for SVR12 testing

From: Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City

Predictor

Treatment completion

Return for SVR 12

OR

95% CI

OR

95% CI

Age

1

0.9–1.0

1

0.97–1.03

Female

0.8

0.3–2.3

0.6

0.3–1.2

Ethnicity

White

Reference

   

Black or African-American

1.1

0.2–4.8

0.7

0.3–1.8

Hispanic

0.6

0.2–2.1

0.7

0.3–1.4

Other

0.8

0.2–3.3

0.9

0.3–2.3

Uses medicaid

0.7

0.2–2.5

0.3

0.1–0.7

Cirrhosis

0.8

0.3–2.3

2

0.9–4.8

Diabetes

1.4

0.3–5.5

2.5

0.9–7.2

Other comorbidity

1.2

0.5–2.9

1.5

0.8–2.7

Current substance use

0.8

0.3–2.2

1

0.5–1.9

Current psychiatric Illness

0.9

0.4–2.2

1.6

0.8–3.3

Lifetime substance use

2.1

0.3–13.7

0.5

0.1–2.5

Lifetime psychiatric Illness

1.3

0.2–6.6

1.6

0.5–4.8

Incarceration history

Never

Reference

   

 < 5 years ago

0.6

0.2–2.1

1.3

0.5–3.2

 > 5 years ago

1.1

0.3–3.5

0.9

0.4–2.0

Methadone use

0.6

0.2–2.1

0.5

0.2–1.1

Unstable housing status

0.3

0.1–0.9

1.2

0.6–2.4

  1. *Statistically significant findings bolded